ARCT - Arcturus Therapeutics Q4 2023 Earnings Preview
2024-03-06 17:20:32 ET
More on Arcturus Therapeutics
- Why Arcturus Therapeutics Has A Promising Future With Innovative CF And COVID Treatments
- Arcturus: H1 2024 Rare Disease Drug Data On Deck
- Arcturus gets EU orphan drug status for cystic fibrosis drug
- Canaccord starts Arcturus at buy; cites CF drug, COVID-19 vaccine
- Seeking Alpha’s Quant Rating on Arcturus Therapeutics